D000912Chemicals & DrugsD12.776.124.486.485.114.240D12.776.124.790.651.114.240D12.776.377.715.548.114.2406120.989054Antibodies, NeoplasmFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonWake Forest School of MedicineAlanFarneyAlan C. Farney MD36.08959100000000-80.2685990000000022Farney, AlanProfessorMichaelGautreauxMichael D. Gautreaux PhD36.05970700000000-80.29868100000000633Gautreaux, MichaelAssociate ProfessorRobertStrattaRobert J. Stratta MD36.08919100000000-80.26677800000000846Stratta, RobertProfessorCarlyleHamsherCarlyle P. Hamsher MD36.09003100000000-80.268028000000002204Hamsher, CarlyleProfessor24Assistant Professor19328912Schneeberger S, Landin L, Kaufmann C, Gorantla VS, Brandacher G, Cavadas P, Lee WP, Breidenbach WC, Margreiter RTransplantation proceedingsSchneeberger S, Landin L, Kaufmann C, Gorantla VS, Brandacher G, Cavadas P, Lee WP, Breidenbach WC, Margreiter R. Alemtuzumab: key for minimization of maintenance immunosuppression in reconstructive transplantation? Transplant Proc. 2009 Mar; 41(2):499-502.Transplant Proc2009-03-01T00:00:002009Alemtuzumab: key for minimization of maintenance immunosuppression in reconstructive transplantation?Internal Medicine, Hematology & OncologyInternal Medicine, Molecular MedicinePHS-Biostatistics and Data Science (Public Health Sciences)Surgery, Transplanttrue1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessorPierreTriozziPierre L. Triozzi MD36.09103700000000-80.269096000000001638Triozzi, PierreProfessor18217904Farney A, Sundberg A, Moore P, Hartmann E, Rogers J, Doares W, Jarrett A, Adams P, Stratta RClinical transplantationFarney A, Sundberg A, Moore P, Hartmann E, Rogers J, Doares W, Jarrett A, Adams P, Stratta R. A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation. Clin Transplant. 2008 Jan-Feb; 22(1):41-9.Clin Transplant2008-01-01T00:00:002008A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation.19863336Byrd JC, Peterson BL, Rai KR, Hurd D, Hohl R, Perry MC, Gockerman J, Nattam S, Larson RALeukemia & lymphomaByrd JC, Peterson BL, Rai KR, Hurd D, Hohl R, Perry MC, Gockerman J, Nattam S, Larson RA. Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901. Leuk Lymphoma. 2009 Oct; 50(10):1589-96.Leuk Lymphoma2009-10-01T00:00:002009Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901.19920781Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJTransplantationFarney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJ. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation. Transplantation. 2009 Sep 27; 88(6):810-9.Transplantation2009-09-27T00:00:002009A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.21841541Uemura T, Ramprasad V, Matsushima K, Shike H, Valania T, Kwon O, Ghahramani N, Shah R, Farooq U, Khan A, Kadry ZTransplantationUemura T, Ramprasad V, Matsushima K, Shike H, Valania T, Kwon O, Ghahramani N, Shah R, Farooq U, Khan A, Kadry Z. Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation. Transplantation. 2011 Sep 27; 92(6):678-85.Transplantation2011-09-27T00:00:002011Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation.0.7079520.08743336research area of0.4226580.06209815subject area for